Stockreport

Plus Therapeutics Announces Dr. Gregory Stein as Head of Clinical Development

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF AUSTIN, Texas, April 01, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that Dr. Gregory Stein has joined the Company [Read more]